Cervical cancer is one of the most prevalent gynecologic malignancies and has remained an intractable cancer over the past decades. We analyzed the aberrant expression patterns of cervical cancer using RNA-Seq data from The Cancer Genome Atlas (TCGA). A total of 3352 differently expressed genes (DEGs) were identified in 306 cervical cancer samples compared with 3 control samples, with 1401 genes upregulated and 1951 downregulated. Under Kaplan-Meier analysis, 76 out of these DEGs with a significantly different survival rate between patients with high and low expression groups were picked out and uploaded to perform Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, which identified a transferrin receptor (TFRC)-involved HIF-1 signaling pathway (p < 0.05). Clinical data analysis showed that high TFRC expression in cervical cancers was associated with incrementally advanced stage, tumor status, and lymph nodes (all p-values <0.05), while multivariate analysis revealed that TFRC remained an independent prognostic variable for poor overall survival. In conclusion, our data indicated that the TFRC-involved HIF-1 signaling pathway may play a crucial role in cervical cancer.
Introduction
Cervical cancer is the second most prevalent gynecologic malignancy among women in the world and one of the most frequent causes of cancer-related deaths among females in less developed countries [1] . With the development of screening test, cervical cancer incidence and mortality rates have declined since the mid-20th century, and rates continue to decline to this day. For the period from 2006 through 2014, delay-adjusted cervical cancer incidence rates have not significantly decreased at an average annual percentage rate of 0.3% per year; and, between 2003 and 2014, cervical cancer mortality rates have declined at an average annual rate of 0.8% [2] . Though, HPV vaccination results in lower prevalence of HPV-related cervical abnormalities and, subsequently, a lower positive predictive value of cytology, the ACS estimates that 13,240 women will be diagnosed with invasive cervical cancer, and 4170 women will die from the disease in the United States in 2018 [3] . Obviously, HPV infection alone is not sufficient for its development [4] . The pathogenesis of cervical cancer is still unclear and probably involves the aberrant expression of numerous oncogenes and tumor suppressors.
Radical surgery and radiotherapy represent effective treatment modalities for cervical cancer, but clinical outcomes and patient prognosis vary significantly. Even in developed countries, cervical cancer remains a major public health problem: in 2000-2007, the 5-year relative survival rate of European women diagnosed with cervical cancer was 62%, ranging from 57% in Eastern Europe to 67% in Northern Europe [5] . Therefore, we urgently need to find new effective prognostic markers and treatment strategies to improve the treatment of cervical cancer.
Recent years, high throughput experiments including gene chips have expanded our understanding underlying mechanisms between cancer development and genomic background. Accompanied by the arrival of the era of big data, microarray-based research has generated large databases of genome-wide gene expression data that are deposited in public archives including The Cancer Genome Atlas (TCGA) [6] . Moreover, the development of bioinformatic technologies for microarray data drives data integration and visualization from lists of differently expressed genes (DEGs) and supports the prediction of functional pathways and protein-protein interactions (PPI)-incorporated network analyses [7, 8] .
In the present study, we listed a series of DEGs associated with survival and identified the survival-based HIF-1 signaling pathway in cervical cancer with TCGA database. Transferrin receptor (TFRC), which was overexpressed in cervical cancer and involved in the HIF-1 pathway, was associated with advanced clinical pathologic characteristics. It was also an independent predictor for survival in cervical cancer.
Materials and methods

Data resources
RNA-Seq gene expression HTSeq-Counts data for the TCGA-CESC Project was downloaded from TCGA official website (https://cancergenome.nih.gov). The corresponding clinical information was downloaded from http://www. cbioportal.org. We collated and extracted the data of 309 samples, including 306 cervical cancer and 3 normal samples, for further analysis.
Gene expression analysis
The gene expression data was obtained as transcription profiles. We applied R packages (edgeR version 3.5.0) to the transcription profiles and tested for differential expression between tumor and normal group samples. The adjusted p values (adj. p) were applied to correct the false positive results. Then the significant DEGs (adj. p < 0.05 and fold change value larger than two) were selected out for the next step analysis.
Survival analysis
Kaplan-Meier analysis (R package 'survival') was performed to assess survival and relapse difference across cases with DEGs [9] , which is further checked by UALCAN at http://ualcan.path.uab.edu [10] . Through monitoring the survival rate of each group, the up-regulated and down-regulated DEGs with a poorer survival rate, respectively, were selected out for the next step analysis.
Pathway enrichment analysis of DEGs
The Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.ad.jp/kegg/) database is a knowledge base for systematic analysis, annotation, and visualization of gene functions. The DAVID (https://david.ncifcrf.gov/) database is a biological database regularly used to facilitate functional annotation and pathway analysis. In order to better understand the biological functions and characteristics, we performed KEGG pathway analyses in the DAVID database to identify signaling pathways that the DEGs might be involved. The human genome was selected as the background list parameter, and P value < 0.05 was set as the cutoff point.
Gene set enrichment analysis
Given a list of genes, ranked by the correlation of their genome-wide expression profiles with one of two phenotypes, GSEAs are widely used in genomic research to identify underlying biological mechanisms (defined by the gene sets), such as Gene Ontology terms and molecular pathways [11] . Gene set permutations were performed 1000 times for each analysis. The nominal p value and normalized enrichment score (NES) were used to sort the pathways enriched in each phenotype.
Statistical analysis
The relationship between TFRC and clinical pathologic features was analyzed with the Wilcoxon signed-rank test and logistic regression. Cox regression and the Kaplan-Meier method were used to evaluate clinicopathologic characteristics associated with overall survival. Multivariate Cox analysis was used to compare the influence of TFRC expression on survival along with other clinical characteristics. The cut-off value of TFRC expression was determined by the best separation for survival calculated through R software.
Results
DEGs with a poorer survival in cervical cancer
To have a better understanding of the relationship between DEGs and patient overall survival, we firstly analyzed the RNA-sequencing data and corresponding clinical data of 306 cervical cancer and 3 normal samples downloaded from TCGA data portal in June 2018 ( Fig. 1) . A total of 3352 DEGs were identified in cervical cancer compared with the control samples, with 1401 genes upregulated and 1951 ones downregulated ( Supplementary Fig. 1 ). In order to reveal the genetic alterations and Kaplan-Meier curves, we conducted the survival package in R software to calculate the best separation for survival curves according to the expression levels of DEGs. These upregulated and downregulated genes with a significantly poorer survival were determined. 76 out of 3352 DEGs were picked over for further study (Table 1) . Kaplan-Meier curves of the partial genes between high expression group and low expression group were shown in Supplementary  Fig. 2 .
KEGG enrichment analysis identified TFRC-related HIF-1 signaling pathway
In order to explore their potential regulatory functions, the 76 selected DEGs were mapped to DAVID database and subjected to KEGG pathway enrichment analysis. To our surprise, 7 genes were enriched in two signaling pathways, including the significant HIF-1 signaling pathway. As an important iron metabolism gene for increasing oxygen delivery, TFRC was involved ( Table 2) .
Clinical evaluation of TFRC expression in cervical cancer
Patient characteristics
The clinical data of 306 primary cervical cancers was downloaded from http://www.cbioportal.org. Patient characteristics are shown in Table 3 . Median age at diagnosis of our study cohort was 46 years old (range 20-88 years old). 78% of the study group were white, 11.2% were black or African American, 7.5% were Asian, and the left 3.4% were other regions or ethnic groups. Most of the patients were cervical squamous cell carcinoma (n = 253, 83.2%), only 27 (8.9%) cases were cervical adenocarcinoma, and 24 (7.9%) were other types. Stage I, II, III, and IV comprised 54.5, 23.2, 15.2, and 7.1%, respectively. The cancer status included 188 cases without tumor (71.8%) and 74 cases with tumor (28.2%). Corpus involvement occurred in 19 (16.1%) of 118 patients. Grade 1, 2, and 3 comprised 6.6, 49.8, and 43.6%, respectively. In our cohort, 44.4% (28/64) of patients had positive margins, 31.1% (60/193) of the patients had lymph node metastasis and 7.9% (10/126) had distant metastasis. Median follow-up for subjects alive at last contact was 21.0 months (range 0-210 months).
TFRC expression and association with clinicopathologic variables
Univariate TFRC expression as a categorical dependent variable (based on the cut-off value of 2.30) was associated with poor prognostic clinicopathologic characteristics (Table 4 ). High TFRC expression in cervical cancers was associated with clinical incrementally advanced stage, tumor status, and lymph nodes involved (all p-values <0.05, Fig. 2a -c). These results suggested that cervical cancer patients with high expression of TFRC are more likely to progress to higher stages and lymph node metastasis than those with low expression of TFRC.
Survival outcomes and multivariate analysis
Kaplan-Meier survival analysis showed that patients with high TFRC expression had a worse prognosis than those with low expression (p < 0.0001, Fig. 2d ). Univariate analysis revealed that high TFRC expression correlated significantly with a poorer overall survival (OS) rate (HR: 2.64, 95% CI: 1.66-4.22; p = 0.000). Other clinicopathological factors associated with poor survival include advanced stage, intrauterine infiltration, lymph node metastasis, lymph-vascular space invasion(LVSI), distant (Table 5a ). In multivariate analysis (Table 5b) , TFRC remained an independent prognostic variable for poor overall survival, with a HR of 1.92 (CI: 1.15-3.19, p = 0.012), along with incremental stage. 
GSEA identified TFRC-related oncogenic signaling pathway
The GSEA method is designed to work with continuous data and searches for gene sets that are enriched at the top (over-expressed vs. control) or bottom (under-expressed) of a ranked list of all genes [11] . Given an ordered list of preliminary screening DEGs according to their correlation with TFRC expression, GSEA was derived to elucidate the significant enriched signaling pathways in enrichment of MSigDB Collection (c6.all.v6.2.symbols.gmt), which represents signatures of cellular pathways often disregulated in cancer, at the phenotype of TFRC expression level. It revealed significant differences (NOM p-value <0.005, FDR q-value <0.075) in eight enriched signaling pathways based on their normalized enrichment score (NES) ( Table 6 ). Figure 3 showed that those oncogenic gene-involved cellular pathways, including NFE2L2, RB, E2F3, RPS14, TBK1, VEGFA, GCNP-SHH, and CSR, were differentially enriched in TFRC high expression phenotype.
Discussion
Although effective prophylactic vaccines against the most important carcinogenic HPV types are available, and early cervical cancer can be treated with surgery or radiation, metastatic cervical cancer is incurable and new therapeutic approaches are urgently needed [12, 13] . In this study, for the first time, we preferentially concentrated on the survival curves according to their expression levels of the DEGs computed from TCGA-CESC data. In order to avoid data loss as far as possible, we relaxed the preliminary screening criteria with adjusted P value <0.05 instead of 0.01. Thus, a relatively larger number of DEGs retained. As survival rate is an important indicator for evaluating the prognosis of a cancer and the value of basic research in molecular mechanisms is ultimately assessed by clinical transformation, we focused on filtrating the aberrant genes, which were associated with poor survivals. For the first time, we systematically analyzed DEGs associated with survival in cervical cancer, which will help us to comprehensively understand the molecular mechanisms of cervical cancer. And as a result, 76 out of 3352 DEGs with a significantly poorer survival were identified. Among these selected genes, some were deeply studied like HOXA1 and MMP19, while mechanisms and functions of others were not very clear like SYNC and SERPINB4. Thus, our computer calculated results provided a broad idea for researchers to investigate progress mechanism of cervical cancer. As an example for further study the roles of these genes and the related biologic functions, we performed KEGG pathway enrichment analysis with the 76 picked DEGs. Surprisingly, we discovered that TFRC-involved HIF-1 signaling pathway is strongly associated with human cervical cancer. As known, under certain circumstances like oxidative stress, inflammation, and hypoxia, HIF expression is induced to bind IRP1 and IRP2, which can promote TFRC transcription. HIF-1α also can regulate the transcription of TFRC by binding DNA, subsequent generated TFRC protein can promote iron metabolism for increasing oxygen delivery [14] . Then, in turn, we assessed the clinical evaluation upon the TFRC expression level. Interestingly, beyond that patients who carried higher TFRC expression bore a poorer survival, TFRC had a positive relationship with tumor status, clinical stage, and pelvic lymph nodes metastasis and it remained an independent prognostic variable for poor overall survival determined by multivariate analysis. At last, GSEA further revealed that TFRC may be involved in several oncogenic pathways. Hypoxia is a predominant feature and HIF-1 pathway plays an very important role in cervical cancer, as well as a wide range of solid tumor [15] [16] [17] . As known, the effect of high risk HPV oncogenes E6 and E7 is to degrade p53 and inactivate phosphorylated Rb, respectively, ultimately leading to HIF-1alpha expression, increased VEGF expression, and tumor angiogenesis [18] [19] [20] . The HIF-α proteins are not hydroxylated under hypoxic conditions, leading to stabilization and translocation to the nucleus where they combine with constitutionally expressed HIF-1β to form heterodimers that bind to hypoxia response elements in a wide range of promoters and induce the expression of target genes [21] . This leads to a constitutionally active HIF pathway resulting in each step of the tumor metastasis process, from the initial EMT to the ultimate organotropic colonization [22, 23] .
The HIF-1 pathway is also implicated in the metabolic abnormality, which may cause increase of anaerobic glycolysis in cancer by increasing the transcription of GLUTs, LDHA, and PDK1. Cellular metabolism remodeled by the excess lactate constitutes a recurrent pattern that correlates with tumor stage and severity, as demonstrated by TCGA Research Network [23] [24] [25] , which is consistent with that in cervical cancer [26] .
The HIF pathway is also related with radioresistance. Extra generated 5-ribose phosphate, NADPH, and glutathione reductase through HIF pathway can counter the reactive oxygen species formed by radiation therapy and increase the risk of DNA self-repair, and significantly limit the therapeutic efficiency [27] . Previous study has also demonstrated that overexpression of HIF-1 indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer [28] . The HIF pathway has been implicated in conferring chemoresistance to various chemotherapeutic drugs as well [29, 30] . Though, HIF-1α siRNA has been widely applied to targeted hypoxic tumors to downregulate HIF-1α expression, so as to surmount hypoxiaassociated resistance [27, [31] [32] [33] , the clinical effect needs further study and confirmation, especially in cervical cancer.
As mentioned above, intratumoral hypoxia (reduced O 2 availability) is common in human cancer and promotes activity of HIFs, which leads to aberrant alteration of genes that contribute to angiogenesis, metabolic reprogramming, a Categorical dependent variable, greater or less than the best cutoff expression level for survival curves extracellular matrix remodeling, epithelial-mesenchymal transition, motility, invasion, metastasis, cancer stem cell maintenance, immune evasion, and resistance to chemotherapy and radiation therapy [34, 35] . We also detected expression levels of these related HIF target genes in our TCGA dataset. It was interesting that quite a number of these genes were significantly regulated in cervical cancer compared to normal samples ( Supplementary Tab. 1) , which indicated the important role of HIF pathway in cervical cancer. As an important element, iron plays very important roles in various physiological and pathological processes. Disorders of iron metabolism, especially excessive iron acquisition and retention, can induce tumorigenesis and cancer process [36, 37] . TFRC is a type II transmembrane glycoprotein found on all nuclear cells whose primary function is to uptake iron by binding to Fe3 + -loaded transferrin and subsequent endocytosis. Accumulating evidence has proven that TFRC, as the most important iron transporter for cells to absorb iron, participated in tumor onset and progression with its significantly dysregulated expression in many cancers, including cervical cancer [38, 39] . The aberrant TFRC was also reported to have influence on chemoresponse and matter clinical outcomes in several cancers [40] . Various evidence showed that TFRC-encoded TfR1 played an important role in immunology. Iron endocytosis mediated by TfR1 was essential for lymphocyte development and proliferation [41, 42] . However, additional insufficient iron uptake resulted in the defective lymphocyte activation and disability of antibody production [43] . Enriched TfR1 erythroid cells in neonates suppress systemic immune cell activation and compromise neonatal host defense [44] . The elevated levels of TfR in malignancies, its relevance in cancer, and the extracellular accessibility of this molecule made it an excellent antigen for the treatment of cancer using antibodies. Antibodies targeting TfR have shown anticancer activity against B-cell and other hematologic malignancies [45] [46] [47] . However, further studies are warranted to explore this anti-cancer possibility, especially in solid malignancies, including cervical cancer.
In our study, based on the TCGA data, we firstly demonstrated that overexpression of TFRC in cervical cancer was associated with advanced clinical pathologic characteristics and predicts poor prognosis. A further analysis revealed that there were no significant different mutation or methylation levels between high and low TFRC groups, which indicated that the high expression of TFRC resulted from none of them ( Supplementary Fig. 3A and B ).
Since infection of HPV is the most common cause of cervical cancer, we also performed TFRC expression analysis on 178 cases with known information on HPV infection history [12] . Surprisingly, HPV infection patients (n = 169) did not have a higher TFRC expression level than noninfection patients (n = 9) ( Supplementary Fig. 3C ). We then did GSEA analysis in oncogenic gene sets enrichment of MSigDB Collection (c6.all.v6.2.symbols.gmt) at the phenotype of TFRC expression level. The result showed that several oncogenic gene pathways were differentially enriched in TFRC high expression phenotype. These above all, suggested that TFRC may serve as a potential prognostic marker and therapeutic target in cervical cancer. Recently, there are several studies on cervical cancer using TCGA data. Most of them focused on HPV related genes [48] [49] [50] . Chen et al. also identified a TFRC-contained novel immune gene signature for HPV positive samples that is potentially associated with early relapse of cervical cancer [50] . Li et al. published their systematical analysis of the aberrant expression patterns of cervical cancer using TCGA RNA-Seq data, providing evidence that two SLE associated gene sets (HIST1H2BD and HIST1H2BJ; and HIST1H2BD, HIST1H2BJ, HIST1H2BH, HIST1H2AM, and HIST1H4K) can be used as prognostic factors for survival prediction among cervical cancer patients [51] . However, different data of concern leads to different analysis results, though studies all used TCGA data of cervical cancer.
In conclusion, our results systematically provided a broad idea for researchers to investigate progress mechanism of cervical cancer with the selected 76 DEGs associated with survival. Furthermore, we indicated that the TFRCinvolved HIF-1 signaling pathway may play crucial roles in cervical cancer. Therefore, further experimental studies, with larger sample sizes, are required to validate these findings.
